News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Sernova Announces Marketed Public Offering of Units Canada NewsWire LONDON, ON and BOSTON, June 6, 2024 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...
Concerned Shareholders of Sernova Corp. Wish to Thank All Shareholders Canada NewsWire TORONTO, April 25, 2023 TORONTO, April 25, 2023 /CNW/ - The group of longstanding shareholders (the...
Concerned Shareholders of Sernova Corp. Stand by their Statements Canada NewsWire TORONTO, April 17, 2023 TORONTO, April 17, 2023 /CNW/ - The group of longstanding shareholders (the...
Concerned Shareholders of Sernova Corp. Nominate Two Highly Qualified Directors to the Board Canada NewsWire TORONTO, April 3, 2023 Concerned shareholder group has issued an information circular...
Advance Notice Filed with Sernova Corp. for the Nomination of Two Director Nominees Canada NewsWire TORONTO, March 22, 2023 TORONTO, March 22, 2023 /CNW/ - Betty Anne Millar has filed a notice...
BEIJING, Feb. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced the completion by its subsidiary, Sinovac Beijing, of the...
BEIJING, Feb. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, announced today that the underwriters of its...
BEIJING, Jan. 20 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced that it plans to sell, subject to market and other...
BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed the application with China's...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
